<DOC>
	<DOCNO>NCT01334697</DOCNO>
	<brief_summary>The general aim study determinate safety , tolerability early pharmacokinetics cardiotrophin.1 healthy volunteer .</brief_summary>
	<brief_title>Clinical Trial Assess Safety , Tolerability Pharmacokinetics Cardiotrophin-1 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male Female , age 18 55 . Healthy condition ( suffer know acute chronic disease ) No clinically important abnormal physical laboratory finding screen examination . Normal clinically acceptable ECG . Normal blood pressure ( systolic : 90140 mmHg ; diastolic : 5090 mmHg ) heart rate ( 40100 bpm ) . Body Mass Index 19.029.0 ( kg/m2 ) . Ability communicate well investigator comply requirement entire study . Willingness give write informed consent ( prior studyrelated procedure perform ) able adhere study restriction examination schedule . For female subject childbearing potential : use know highly effective method birth control , define result low failure rate : i.e . le 1 % per year , ( contraceptive pill , intrauterine contraceptive device , implant , vasectomized partner sexual abstinence ) , least three consecutive month prior study , study one month end study . For male subject partner child bear potential : use appropriate contraceptive method ( vasectomy , condom sexual abstinence ) , least study period one month end study . Administration investigational drug period within three month prior inform consent . Use prescription medication period 0 30 day overthecounter medication 0 5 day entry study . Donation loss great 400 ml blood period 0 12 week entry study . Serious adverse reaction hypersensitivity drug . Inability communicate cooperate investigator language problem , poor mental development impair cerebral function . History drug dependence ( except tobacco ) psychiatric illness within past 2 year . Consumption alcohol within 24 hour prior dose administration . Presence pain incur unknown cause . Pregnancy nursing . Positive urine drug screen drug high potential abuse low persistence urine . Inability refrain smoke study day . Any condition , opinion investigator , likely interfere successful collection measure require study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Cardiotrophin-1</keyword>
	<keyword>CT-1</keyword>
</DOC>